Skip to content

Clinical application of stromal vascular fraction gel in the treatment of hypertrophic scars

Clinical application of stromal vascular fraction gel in the treatment of hypertrophic scars

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029368
Enrollment
Unknown
Registered
2020-01-26
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic scar

Interventions

control group:Glucocorticoid group

Sponsors

Department of Surgery, Zunyi Medical University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with hypertrophic scar; (2) hypertrophic scaris in mature phase; (3) aged 18-60 years; (4) subject or legal representative informed consent, volunteered to test, and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) patients undergoing hormone, anti-scar medications and other treatments; (2) there are other basic diseases such as cardiovascular and cerebrovascular diseases; (3) pregnant, pregnant or lactating subjects; (4) Serious systemic or local skin infection; (5) participating in other clinical trials within 3 months; (6) the patient cannot cooperate with the trial-related content due to various reasons such as mental, cognitive, and language.

Design outcomes

Primary

MeasureTime frame
scar score;

Countries

China

Contacts

Public ContactChenliang Deng

Zunyi Medical College Hospital

cheliadeng@sina.com+86 15085115296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026